18 results
P
patients with rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA)
I/C
coeliac disease (CD), biopsy-confirmed CD in RA and JIA patients
O
pooled prevalence estimates of biopsy-confirmed CD and positive CD serology
P
Hu ML, Zheng G, Lin H, Yang M, Zhang YD, Han JM
I/C
Desensitizing Toothpastes
O
Dentine Hypersensitivity
P
5293
I/C
total glucosides of paeony, placebo, standard treatment
O
disease activity score (ASDAS), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), tumor necrosis factor (TNF)-α, interleukin (IL)-6, 28 joints disease activity (DAS28), psoriasis area and severity index (PASI), visual analogue scale (VAS), nitric oxide (NO)
P
patients with carious lesions
I/C
stepwise removal technique, complete removal technique
O
pulp exposure, signs and symptoms of pulp disease, restoration failure
P
lung/gastric/liver cancer patients, controls
I/C
meta-analysis, previous related studies, present study
O
association with cancer susceptibility
P
patients with autoimmune disease and associated inflammatory ocular diseases
I/C
Janus kinase (JAK) inhibitors, . None of these 11 patients responded adequately to conventional treatments, including biological agents; these were all refractory cases and switched to JAK inhibitor therapy.
O
all 11 patients showed an improvement to JAK inhibitors without significant side effects
P
adult population, over 60 years old, under 18 years old
I/C
reminder sent by mail
O
adherence to influenza vaccination
P
792 patients
I/C
literature search using Pubmed, Scopus/EMBASE, and the Cochrane Library databases, seven studies (n=792) in the meta-analysis
O
mean and 95th percentile of the incubation period
P
patients undergoing orthognathic surgery
I/C
long-term antibiotic prophylaxis, short-term antibiotic prophylaxis
O
surgical site infection, hospital stay longer than two days
P
patients with polypoidal choroidal vasculopathy
I/C
anti-vascular endothelial growth factor drugs, photodynamic therapy, combination of photodynamic therapy and anti-vascular endothelial growth factor drugs, anti-vascular endothelial growth factor drugs alone
O
incidence of retinal hemorrhage, visual acuity gain, polyp regression, central retinal thickness